Investigating how glycosyl ceramides affect heart failure and recovery
Official title: The Role of Glycosyl Ceramides in Heart Failure and Recovery
Funded at University of Utah · NIH-10896979 · Data updated 2026-11-12
This study is looking at how certain fats in the body affect heart health and recovery in people with heart failure, and it aims to find new ways to improve treatments for patients like you.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Utah NIH-funded |
| Lab location | 1 site (Salt Lake City, United States) |
| Project start | August 1, 2023 |
| Project end | July 31, 2028 |
| Funding year | 2024 |
| Award (this year) | $179,280 |
| NIH project number | 5K08HL168315-02 |
| Project ID | NIH-10896979 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research are adults experiencing heart failure or those at risk of developing heart-related conditions.
✕Less likely to help
Patients with non-cardiac related health issues or those under 21 years old may not receive benefits from this research.
What this research studies
This research focuses on understanding the role of glycosyl ceramides in heart failure and the recovery process. The approach involves studying fatty acid metabolism and its impact on cardiac remodeling through various methodologies, including human studies, animal models, and laboratory assessments. Patients may benefit from insights gained about metabolic mechanisms that influence heart health, potentially leading to improved treatments for heart failure. The research will also include training in advanced techniques for analyzing heart tissue and serum samples.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for treating heart failure and enhancing recovery.
How similar studies have gone: Previous research has shown promising results in understanding metabolic factors in heart failure, indicating that this approach has potential for success.
Where this research is happening
-
University of Utah
Salt Lake City, United States Active
Researchers
- Principal investigator: Tseliou, Eleni — University of Utah
- Study coordinator: Tseliou, Eleni
Related research
Other NIH-funded projects on the same topics.
-
AI-supported heart failure diagnosis and management in Rwanda
Aiming to help people with suspected heart failure in Rwanda get faster, more accurate diagnoses and better care using AI-guided ultrasound and care protocols.
-
AI-assisted heart failure diagnosis in Rwanda using focused ultrasound
An NIH-funded project will test whether AI-enhanced, easy-to-use heart ultrasound can help non-experts diagnose and manage heart failure in Rwanda.
-
HF endotypes in heart failure using ethical multi-modal AI and molecular data
A patient-friendly project that uses advanced AI and multiple kinds of health data to identify distinct heart failure subtypes that could guide personalized care.
-
Triple gene therapy approach to heal the heart after a heart attack
A new therapy combines three genetic approaches delivered by a virus to help the heart heal after a heart attack.
-
Digital-first heart failure care delivery in Uganda
A targeted program in Uganda tests a digital care plan to help people with heart failure manage their symptoms at home.
-
Digital-first heart failure care delivery in Uganda
A study to test digital self-care tools to help people with heart failure in Uganda manage symptoms and stay healthier.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.